SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-043980
Filing Date
2020-04-07 08:40:41
Period of Report
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a20-14980_68k.htm 8-K 42967
2 EX-3.1 a20-14980_6ex3d1.htm EX-3.1 10128
3 EX-3.2 a20-14980_6ex3d2.htm EX-3.2 220513
  Complete submission text file 0001104659-20-043980.txt   275217
Mailing Address 1490 O'BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address 1490 O'BRIEN DRIVE, SUITE A MENLO PARK CA 94025 (650) 352-4150
Forty Seven, Inc. (Filer) CIK: 0001667633 (see all company filings)

IRS No.: 474065674 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38554 | Film No.: 20778490
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences